Gilbert Lynn Marks - 10 Oct 2025 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Gilbert Lynn Marks
Issuer symbol
ANTX
Transactions as of
10 Oct 2025
Net transactions value
$0
Form type
4
Filing time
14 Oct 2025, 16:01:06 UTC
Previous filing
11 Jul 2025
Next filing
14 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Marks Gilbert Lynn Director C/O AN2 THERAPEUTICS, INC., 1300 EL CAMINO REAL, SUITE 100, MENLO PARK /s/ Lucy Day, Attorney-in-Fact for Gilbert Lynn Marks 13 Oct 2025 0001916940

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Award $0 +10,367 +19% $0.000000 63,749 10 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.